View Older Stories View More Recent Stories

Oct 8, 2020 08:00AM Alcon Celebrates World Sight Day 2020 and Continues Commitment to Improving Worldwide Access to Eye Care
Oct 6, 2020 08:15AM Alcon to Showcase Innovations at #Academy20 that Support Recovery and Growth for Eye Care Practices
Oct 2, 2020 09:00AM PM360 Magazine Announces Winners Of 2020 Trailblazer Awards
Sep 25, 2020 08:07AM Graybug Vision Inc. (GRAY) Adds Christina Ackermann, Eric Bjerkholt and Julie Eastland to Board
Sep 25, 2020 08:00AM Graybug Appoints Three New Members to its Board of Directors
Sep 25, 2020 08:00AM Graybug Appoints Three New Members to its Board of Directors
Aug 21, 2020 07:00AM Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer
Aug 20, 2020 08:00AM Alcon and Actress Katherine McNamara Encourage Consumers to See What Happens with PRECISION1® Contact Lenses
Aug 18, 2020 04:56PM Alcon Reports Second Quarter 2020 Results
Aug 18, 2020 04:30PM Alcon Reports Second Quarter 2020 Results
Aug 18, 2020 09:00AM PM360 Announces 2020 Trailblazer Award Finalists
Aug 13, 2020 09:00AM Model N Continues to Lead in Life Sciences Market
Aug 12, 2020 08:01AM Wishbone Medical Appoints Jeff George to Board of Directors
Aug 3, 2020 02:00AM Oxurion NV appoints Grace Chang, M.D., Ph.D. as Chief Medical Officer
Aug 3, 2020 02:00AM Oxurion NV appoints Grace Chang, M.D., Ph.D. as Chief Medical Officer
Jul 27, 2020 08:00AM Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications
Jul 21, 2020 09:00AM Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eye
Jul 21, 2020 09:00AM Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eye
Jul 21, 2020 01:00AM Novartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales.
Jul 14, 2020 07:53AM Alcon (ALC) Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength
Jul 14, 2020 07:50AM Alcon Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength
Jul 14, 2020 07:50AM Alcon Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength
Jul 6, 2020 11:00AM VisionCare, Inc. Names Thomas Ruggia as New Chief Executive Officer
Jun 25, 2020 01:23PM Novartis, former unit to pay $346 million to resolve U.S. bribery charges
Jun 25, 2020 01:11PM Novartis Resolves Legacy FCPA Investigations
May 15, 2020 06:30AM CENTOGENE Announces Changes in Senior Management Team
May 15, 2020 06:30AM CENTOGENE Announces Changes in Senior Management Team
May 12, 2020 04:30PM Alcon Reports First Quarter 2020 Results
May 12, 2020 04:30PM Alcon Reports First Quarter 2020 Results
Apr 28, 2020 08:30AM BVI Names David Murray as Chief Financial Officer
Apr 28, 2020 01:00AM Novartis maintains strong operational performance in Q1, confirms FY 2020 guidance at this time, and advances a broad range of efforts to support the global response to COVID-19
Apr 9, 2020 08:00AM Tango Therapeutics Raises $60 Million Series B Financing and Strengthens Executive Team
Apr 7, 2020 01:00AM Alcon Provides Update on COVID-19
Apr 7, 2020 01:00AM Alcon Provides Update on COVID-19
Mar 12, 2020 12:45PM Oxurion NV Business Update – FY 2019
Mar 12, 2020 12:45PM Oxurion NV Business Update – FY 2019
Mar 12, 2020 07:00AM Aldeyra Therapeutics (ALDX) Announces Strategic Prioritization of Late-Stage Clinical Pipeline in Ocular Disease
Mar 12, 2020 06:59AM Aldeyra Announces Strategic Prioritization of Late-Stage Clinical Pipeline in Ocular Disease
Mar 11, 2020 02:30AM Nicox to Receive €15 Million and Half of the Cost of the Second NCX 470 Phase 3 Clinical Trial from Ocumension Therapeutics under Amended Agreement
Mar 11, 2020 02:30AM Nicox to Receive €15 Million and Half of the Cost of the Second NCX 470 Phase 3 Clinical Trial from Ocumension Therapeutics under Amended Agreement
Mar 2, 2020 08:15AM Alcon Showcases Contact Lens, Eye Allergy and Dry Eye Innovations as Title Sponsor of #SECO2020
Mar 2, 2020 08:15AM Alcon Showcases Contact Lens, Eye Allergy and Dry Eye Innovations as Title Sponsor of #SECO2020
Feb 25, 2020 04:30PM Alcon Reports Full Year 2019 Results
Feb 25, 2020 04:30PM Alcon Reports Full Year 2019 Results
Feb 25, 2020 09:53AM Edward Jones Reiterates Buy Rating on Novartis (NVS), Favors Attractive Pipeline
Feb 24, 2020 02:16PM Eyevance Pharmaceuticals Appoints Julie Speed as Chief Commercial Officer
Feb 17, 2020 08:00AM Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch
Feb 17, 2020 08:00AM Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch
Feb 13, 2020 01:22PM Vivendi: Strong Earnings Growth In 2019
Feb 6, 2020 01:32AM Publicis Groupe: 2019 Annual Results
View More Recent Stories View Older Stories